Farhad Najmeddin

524 total citations
45 papers, 363 citations indexed

About

Farhad Najmeddin is a scholar working on Epidemiology, Infectious Diseases and Pharmacology. According to data from OpenAlex, Farhad Najmeddin has authored 45 papers receiving a total of 363 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Epidemiology, 14 papers in Infectious Diseases and 11 papers in Pharmacology. Recurrent topics in Farhad Najmeddin's work include Sepsis Diagnosis and Treatment (13 papers), COVID-19 Clinical Research Studies (11 papers) and Antibiotics Pharmacokinetics and Efficacy (11 papers). Farhad Najmeddin is often cited by papers focused on Sepsis Diagnosis and Treatment (13 papers), COVID-19 Clinical Research Studies (11 papers) and Antibiotics Pharmacokinetics and Efficacy (11 papers). Farhad Najmeddin collaborates with scholars based in Iran, Australia and Hungary. Farhad Najmeddin's co-authors include Mojtaba Mojtahedzadeh, Atabak Najafi, Arezoo Ahmadi, Hamidreza Sharifnia, Mohammad Reza Rouini, Haleh Ashraf, Adeleh Sahebnasagh, Maryam Bahreini, Abbas Soleimani and Sarah Mousavi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Current Medicinal Chemistry and American Journal of Hypertension.

In The Last Decade

Farhad Najmeddin

42 papers receiving 356 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Farhad Najmeddin Iran 11 122 92 88 58 41 45 363
Darrel W. Hughes United States 13 132 1.1× 68 0.7× 118 1.3× 68 1.2× 42 1.0× 16 374
Emmanuel Novy France 9 73 0.6× 109 1.2× 142 1.6× 32 0.6× 48 1.2× 33 377
Allison Forni United States 6 42 0.3× 84 0.9× 92 1.0× 58 1.0× 23 0.6× 8 369
Andrew C. Faust United States 11 102 0.8× 66 0.7× 108 1.2× 34 0.6× 10 0.2× 33 398
Régine Vermesch France 10 76 0.6× 66 0.7× 118 1.3× 36 0.6× 58 1.4× 13 393
Mir Mohammad Miri Iran 12 123 1.0× 43 0.5× 74 0.8× 59 1.0× 9 0.2× 53 403
Renae Deans Australia 11 38 0.3× 151 1.6× 86 1.0× 52 0.9× 81 2.0× 14 404
Dinesh Yogaratnam United States 10 43 0.4× 84 0.9× 82 0.9× 31 0.5× 32 0.8× 12 502
Deonne Dersch‐Mills Canada 14 160 1.3× 141 1.5× 85 1.0× 17 0.3× 15 0.4× 49 546
Ahmad Bagheri Moghaddam Iran 13 90 0.7× 30 0.3× 34 0.4× 62 1.1× 14 0.3× 36 468

Countries citing papers authored by Farhad Najmeddin

Since Specialization
Citations

This map shows the geographic impact of Farhad Najmeddin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Farhad Najmeddin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Farhad Najmeddin more than expected).

Fields of papers citing papers by Farhad Najmeddin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Farhad Najmeddin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Farhad Najmeddin. The network helps show where Farhad Najmeddin may publish in the future.

Co-authorship network of co-authors of Farhad Najmeddin

This figure shows the co-authorship network connecting the top 25 collaborators of Farhad Najmeddin. A scholar is included among the top collaborators of Farhad Najmeddin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Farhad Najmeddin. Farhad Najmeddin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kianpour, Parisa, et al.. (2024). Enhancing analgesia in acute renal colic pain: a randomized controlled trial of gabapentin adjunct to ketorolac-based regimen. SHILAP Revista de lepidopterología. 5. 1427711–1427711. 1 indexed citations
2.
Kianpour, Parisa, Sajad Sahab Negah, Yunes Panahi, et al.. (2024). Clinical Evaluation of Umifenovir as a Potential Antiviral Therapy for COVID-19: A Multi-center, Randomized, Controlled Clinical Trial. Oman Medical Journal. 40(1). e716–e716.
3.
Mojtahedzadeh, Mojtaba, et al.. (2024). Intragastric Botulinum Toxin Injection and Botulism: An Alarm for Clinicians. Case Reports in Critical Care. 2024(1). 8183127–8183127. 1 indexed citations
4.
Davoudi-Monfared, Effat, et al.. (2023). Effect of Famotidine on COVID-19: Killing Virus or Opposing ARDS?. Pulmonary Therapy. 9(2). 173–175. 1 indexed citations
5.
Rouini, Mohammad Reza, Atabak Najafi, Arezoo Ahmadi, et al.. (2022). Pharmacokinetic study of high-dose oral rifampicin in critically Ill patients with multidrug-resistant Acinetobacter baumannii infection. DARU Journal of Pharmaceutical Sciences. 30(2). 311–322. 2 indexed citations
6.
Najmeddin, Farhad, et al.. (2022). LipoxinA4 as a Potential Prognostic Marker of COVID-19. SHILAP Revista de lepidopterología. 2022. 1–3. 2 indexed citations
7.
Najmeddin, Farhad, et al.. (2022). Identification of drug‐related problems followed by clinical pharmacist interventions in an outpatient pharmacotherapy clinic. Journal of Clinical Pharmacy and Therapeutics. 47(7). 964–972. 9 indexed citations
8.
Najmeddin, Farhad, et al.. (2021). Antibiotic therapy in sepsis: No next time for a second chance!. Journal of Clinical Pharmacy and Therapeutics. 46(4). 872–876. 12 indexed citations
9.
10.
Sahebnasagh, Adeleh, Farhad Najmeddin, Atabak Najafi, et al.. (2020). A Perspective on Erythropoietin as a Potential Adjuvant Therapy for Acute Lung Injury/Acute Respiratory Distress Syndrome in Patients with COVID-19. Archives of Medical Research. 51(7). 631–635. 21 indexed citations
11.
Payandemehr, Pooya, Morteza Azhdarzadeh, Hooman Bahrami‐Motlagh, et al.. (2020). Interferon beta-1a as a Candidate for COVID-19 Treatment; An Open-Label Single-Arm Clinical Trial. SHILAP Revista de lepidopterología. 10 indexed citations
12.
Najmeddin, Farhad, et al.. (2020). Area under the Curve-Based Dosing of Vancomycin in Critically Ill Patients Using 6-Hour Urine Creatinine Clearance Measurement. Critical Care Research and Practice. 2020. 1–6. 5 indexed citations
13.
Soleimani, Abbas, Arya Aminorroaya, Mohammad Talebpour, et al.. (2020). Effects of Angiotensin Receptor Blockers (ARBs) on In-Hospital Outcomes of Patients With Hypertension and Confirmed or Clinically Suspected COVID-19. American Journal of Hypertension. 33(12). 1102–1111. 34 indexed citations
14.
Najmeddin, Farhad, Mohammad Reza Rouini, Atabak Najafi, et al.. (2019). Evaluation of Amikacin Pharmacokinetics in Critically Ill Patients with Intra-abdominal Sepsis. Advanced Pharmaceutical Bulletin. 10(1). 114–118. 8 indexed citations
15.
Tigabu, Bereket Molla, et al.. (2019). A Cost-effectiveness Analysis of Albumin in Septic Shock: A Patient-level Data Analysis. Clinical Therapeutics. 41(11). 2297–2307.e2. 7 indexed citations
16.
Najmeddin, Farhad, Mohammad Reza Rouini, Atabak Najafi, et al.. (2018). Evaluation of Epithelial Lining Fluid Concentration of Amikacin in Critically Ill Patients With Ventilator-Associated Pneumonia. Journal of Intensive Care Medicine. 35(4). 400–404. 34 indexed citations
17.
Mojtahedzadeh, Mojtaba, et al.. (2016). Randomized Trial of the Effect of Magnesium Sulfate Continuous Infusion on IL-6 and CRP Serum Levels Following Abdominal Aortic Aneurysm Surgery.. PubMed. 15(4). 951–956. 7 indexed citations
18.
Najmeddin, Farhad, et al.. (2015). Therapeutic Drug Monitoring of Vancomycin Following Critical Care Illnesses: Peak Concentration Determination Maybe Critical. SHILAP Revista de lepidopterología. 2 indexed citations
19.
Najmeddin, Farhad, Arezoo Ahmadi, Laleh Mahmoudi, et al.. (2014). Administration of higher doses of Amikacin in early stages of sepsis in critically ill patients. SHILAP Revista de lepidopterología. 6 indexed citations
20.
Rashidi, Batool Hossein, et al.. (2011). Prevalence of the insulin receptor substrate-1(IRS-1) Gly972Arg and the insulin receptor substrate-2(IRS-2) Gly1057Asp polymorphisms in PCOS patients and non-diabetic healthy women. Journal of Assisted Reproduction and Genetics. 29(2). 195–201. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Darrel W. Hughes Breakdown of academic impact, for papers by Emmanuel Novy Breakdown of academic impact, for papers by Allison Forni Breakdown of academic impact, for papers by Andrew C. Faust Breakdown of academic impact, for papers by Régine Vermesch Breakdown of academic impact, for papers by Mir Mohammad Miri Breakdown of academic impact, for papers by Renae Deans Breakdown of academic impact, for papers by Dinesh Yogaratnam Breakdown of academic impact, for papers by Deonne Dersch‐Mills Breakdown of academic impact, for papers by Ahmad Bagheri Moghaddam
Rankless by CCL
2026